Cytosorbents (CTSO) FCF Margin (2011 - 2026)
Cytosorbents' (CTSO) quarterly FCF Margin came in at 13.23% in Q1 2026, up 2651.0% YoY from 0.48% in Q1 2025, and up 75.23% on a QoQ basis from 53.42% in Q4 2025.
Cytosorbents (CTSO) FCF Margin (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of FCF Margin data on file, last reported at 13.23% in Q1 2026.
- Quarterly FCF Margin rose 2651.0% year-over-year to 13.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27.54% (up 933.0% YoY) and the FY2025 annual result came in at 33.84%, up 672.0% from the prior year.
- FCF Margin improved to 13.23% in Q1 2026, from 53.42% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1.85% in Q4 2022 to a low of 152.61% in Q3 2022.
- A 5-year average of 52.89% and a median of 53.42% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 12273 bps — and 2023, when it surged 9352 bps.
- Tracing CTSO's FCF Margin over 5 years: stood at 1.85% in 2022, then sank by 4433 bps to 80.13% in 2023, then surged by 71 bps to 23.32% in 2024, then tumbled by 129 bps to 53.42% in 2025, then surged by 75 bps to 13.23% in 2026.
- The last three FCF Margin figures came in at 13.23% (Q1 2026), 53.42% (Q4 2025), and 27.35% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.73% |
| 10 | Cytosorbents | 20.86 Mn | 16.45 Mn | 7.05 Mn | -6.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.20% |
| Mar 31, 2026 | -13.23% |
| Dec 31, 2025 | -53.42% |
| Sep 30, 2025 | -27.35% |
| Jun 30, 2025 | -16.08% |
| Mar 31, 2025 | -39.74% |
| Dec 31, 2024 | -23.32% |
| Sep 30, 2024 | -30.36% |
| Jun 30, 2024 | -54.42% |
| Mar 31, 2024 | -54.23% |
| Dec 31, 2023 | -80.13% |
| Sep 30, 2023 | -59.09% |
| Jun 30, 2023 | -73.60% |
| Mar 31, 2023 | -32.89% |
| Dec 31, 2022 | 1.85% |
| Sep 30, 2022 | -152.61% |
| Jun 30, 2022 | -88.98% |
| Mar 31, 2022 | -101.59% |
| Dec 31, 2021 | -84.70% |
| Sep 30, 2021 | -29.88% |